Literature DB >> 11505444

Changing prevalence of hepatitis C virus genotypes: molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in Taiwan.

M L Yu1, W L Chuang, S C Chen, C Y Dai, C Hou, J H Wang, S N Lu, J F Huang, Z Y Lin, M Y Hsieh, J F Tsai, L Y Wang, W Y Chang.   

Abstract

To determine the hepatitis C virus (HCV) genotype distribution in Taiwan and to clarify the relationship between genotype and the pathogenesis of HCV infection, 1,164 subjects positive for serum HCV antibodies and HCV RNA from three HCV hyperendemic areas (Masago, Tzukuan, and Taoyuan) and a tertiary referral center in Taiwan were studied during 1995-1997. HCV genotypes and viral loads were determined using Okamoto's method and branched DNA assay, respectively. Genotype 1b was the most prevalent in Tzukuan (61.9%), Taoyuan (76.9%), and the referral center (47.0%). By contrast, genotype 2a was the major HCV type in Masago (63.5%). Prevalence of genotype 1b positively and that of genotype 2a negatively correlated to age, regardless of study populations (P < 0.01). Based on multivariate analysis, the significant factors associated with the presence of cirrhosis, with or without hepatocellular carcinoma, in chronic hepatitis C patients were genotype 1b and age. In conclusion, these results underline that independent HCV outbreaks continue in HCV hyperendemic areas in Taiwan, concomitant with a changing relative prevalence of HCV genotypes in relation to age. Both the correlation of genotype 1b with age (cohort effect) and intrinsic properties of HCV genotypes are probably responsible for the association between genotype and the pathogenesis of HCV infection. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11505444

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  24 in total

1.  Superior response to pegylated interferon and ribavirin in Asians with chronic hepatitis C.

Authors:  Venessa Pattullo; E Jenny Heathcote; David K H Wong
Journal:  Hepatol Int       Date:  2010-08-08       Impact factor: 6.047

2.  Novel quasi-subgenotype D2 of hepatitis B virus identified in Taiwanese aborigines.

Authors:  Huy Tran; Ming-Lung Yu; Chia-Yen Dai; I-Ling Lin; Ming-Lun Yeh; Wan-Long Chuang; Kenji Abe
Journal:  Virus Genes       Date:  2014-05-03       Impact factor: 2.332

3.  Prevalence and clinical significance of SEN virus infection among volunteer blood donors in southern Taiwan.

Authors:  Chia-Yen Dai; Ming-Lung Yu; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Jung-Fa Tsai; Wan-Long Chuang; Wen-Yu Chan
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

4.  The unique HCV genotype distribution and the discovery of a novel subtype 6u among IDUs co-infected with HIV-1 in Yunnan, China.

Authors:  Xueshan Xia; Ling Lu; Kok Keng Tee; Wenhua Zhao; Jianguo Wu; Jing Yu; Xiaojie Li; Yixiong Lin; Muhammad Mahmood Mukhtar; Curt H Hagedorn; Yutaka Takebe
Journal:  J Med Virol       Date:  2008-07       Impact factor: 2.327

Review 5.  Epidemiology and natural history of hepatitis C virus infection.

Authors:  Mei-Hsuan Lee; Hwai-I Yang; Yong Yuan; Gilbert L'Italien; Chien-Jen Chen
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

6.  Increased Risk of Age-Related Macular Degeneration with Chronic Hepatitis C Virus Infection: A Nationwide Population-Based Propensity Score-Matched Cohort Study in Taiwan.

Authors:  Chih-Ching Yeh; Meei-Maan Wu; Chia-Min Wu; Fung-Chang Sung; Chih-Hsin Muo; Arlene Te; Fu-Hsiung Su
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

Review 7.  Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries.

Authors:  Masao Omata; Tatsuo Kanda; Osamu Yokosuka; Darrell Crawford; Mamun Al-Mahtab; Lai Wei; Alaaeldin Ibrahim; George K K Lau; Barjesh C Sharma; Saeed S Hamid; Wan-Long Chuang; A Kadir Dokmeci
Journal:  Hepatol Int       Date:  2015-05-05       Impact factor: 9.029

8.  High versus standard doses interferon-alpha in the treatment of naïve chronic hepatitis C patients in Taiwan: a 10-year cohort study.

Authors:  Ming-Lung Yu; Chia-Yen Dai; Shinn-Cherng Chen; Li-Po Lee; Ming-Yen Hsieh; Zu-Yau Lin; Ming-Yuh Hsieh; Liang-Yen Wang; Jung-Fa Tsai; Wen-Yu Chang; Wan-Long Chuang
Journal:  BMC Infect Dis       Date:  2005-04-12       Impact factor: 3.090

9.  Distinct patterns of the lipid alterations between genotype 1 and 2 chronic hepatitis C patients after viral clearance.

Authors:  Ming-Ling Chang; Yung-Kuan Tsou; Tsung-Hui Hu; Cheng-Hui Lin; Wey-Ran Lin; Chang-Mu Sung; Tsung-Hsing Chen; Mei-Ling Cheng; Kuo-Chin Chang; Cheng-Tang Chiu; Chau-Ting Yeh; Jong-Hwei Su Pang; Ming-Shi Shiao
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

10.  Hepatitis C virus infection among injection drug users with and without human immunodeficiency virus co-infection.

Authors:  Meng-Hsuan Hsieh; Jih-Jin Tsai; Ming-Yen Hsieh; Chung-Feng Huang; Ming-Lun Yeh; Jeng-Fu Yang; Ko Chang; Wei-Ru Lin; Chun-Yu Lin; Tun-Chieh Chen; Jee-Fu Huang; Chia-Yen Dai; Ming-Lung Yu; Wan-Long Chuang
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.